Latest American Association for Cancer Research Stories
ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for
Regis Technologies, Inc., a Chicago-based CMO focused on the cGMP scale up of small molecule API’s, will
BOSTON, April 16, 2015 /PRNewswire/ -- AbVitro Inc., a therapeutic and target discovery company announced that it will be presenting data on the Identification of Novel Pancreatic Cancer-Specific
Debiopharm presents preclinical results for 2 anti-cancer targeted therapies Debio 1143 and Debio 1347 LAUSANNE, Switzerland, April 16, 2015 /PRNewswire/ -- Debiopharm International
BURLINGAME, Calif., April 16, 2015 /PRNewswire/ -- Scientists from Cleave Biosciences will be participating in the special session, "New Drugs on the Horizon," at the American Association for
SEATTLE, April 15, 2015 /PRNewswire/ -- Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present
MADRID, April 14, 2015 /PRNewswire/ -- - Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic
Multi-omics approach to elucidate mechanism of cancer drug resistance PHILADELPHIA, April 13, 2015 /PRNewswire/ -- ChemPartner, a leading science driven, technology based, high
CAMBRIDGE, Mass., April 8, 2015 /PRNewswire/ -- Blueprint Medicines today announced it will present new preclinical data on its drug candidate BLU-285 in gastrointestinal stromal tumors (GIST), as
Thomas Jefferson University, University of California at San Francisco, MD Anderson and University of Pennsylvania to present data on a liquid biopsy platform for genomic sequencing at AACR.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.